(Q38660724)

1 July 2019

title

Opioids for chronic non-cancer pain in children and adolescents (English)

1 reference

1 July 2019

0 references

6

1 reference

1 July 2019

Philip J Wiffen

8

1 reference

1 July 2019

author name string

Tess E Cooper

1

1 reference

1 July 2019

Emma Fisher

2

1 reference

1 July 2019

Andrew L Gray

3

1 reference

1 July 2019

Elliot Krane

4

1 reference

1 July 2019

Navil Sethna

5

1 reference

1 July 2019

Boris Zernikow

7

1 reference

1 July 2019

publication date

26 July 2017

1 reference

1 July 2019

Cochrane Database of Systematic Reviews

published in

1 reference

1 July 2019

volume

7

1 reference

1 July 2019

page(s)

CD012538

1 reference

1 July 2019

Relationship between change in pain intensity and functional outcomes in patients with chronic pain receiving twice daily extended-release hydrocodone bitartrate

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012538.PUB2

Two comparisons of the analgesic activity of orally administered pentazocine, dihydrocodeine and placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012538.PUB2

Double-Blind Oral Analgesic Study of Butorphanol in Musculoskeletal Pain: A Comparison with Codeine and Placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012538.PUB2

Gastrointestinal events after opioid treatment in nonmalignant pain: correlates of occurrence and impact on health-related quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012538.PUB2

Oral administration of morphine versus ibuprofen to manage postfracture pain in children: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012538.PUB2

Long-Term Effects of Neonatal Morphine Infusion on Pain Sensitivity: Follow-Up of a Randomized Controlled Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012538.PUB2

A comprehensive categorical and bibliometric analysis of published research articles on pediatric pain from 1975 to 2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012538.PUB2

Antidepressants for chronic non-cancer pain in children and adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012538.PUB2

Non-steroidal anti-inflammatory drugs (NSAIDs) for cancer-related pain in children and adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012538.PUB2

Paracetamol (acetaminophen) for chronic non-cancer pain in children and adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012538.PUB2

CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012538.PUB2

Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012538.PUB2

Managing chronic pain in children and adolescents. We need to address the embarrassing lack of data for this common problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012538.PUB2

Non-steroidal anti-inflammatory drugs (NSAIDs) for chronic non-cancer pain in children and adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012538.PUB2

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012538.PUB2

GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012538.PUB2

GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012538.PUB2

GRADE guidelines: 12. Preparing summary of findings tables-binary outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012538.PUB2

How do changes in pain severity levels correspond to changes in health status and function in patients with painful diabetic peripheral neuropathy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012538.PUB2

Meta-analysis in clinical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012538.PUB2

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012538.PUB2

Pregabalin for acute and chronic pain in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012538.PUB2

"Evidence" in chronic pain--establishing best practice in the reporting of systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012538.PUB2

Fibromyalgia: Moderate and substantial pain intensity reduction predicts improvement in other outcomes and substantial quality of life gain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012538.PUB2

Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012538.PUB2

Clinical effectiveness: an approach to clinical trial design more relevant to clinical practice, acknowledging the importance of individual differences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012538.PUB2

Minimum efficacy criteria for comparisons between treatments using individual patient meta-analysis of acute pain trials: examples of etoricoxib, paracetamol, ibuprofen, and ibuprofen/paracetamol combinations after third molar extraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012538.PUB2

Mean analgesic consumption is inappropriate for testing analgesic efficacy in post-operative pain: analysis and alternative suggestion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012538.PUB2

Estimate at your peril: imputation methods for patient withdrawal can bias efficacy outcomes in chronic pain trials using responder analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012538.PUB2

Pain measures and cut-offs - 'no worse than mild pain' as a simple, universal outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012538.PUB2

Expect analgesic failure; pursue analgesic success

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012538.PUB2

The costs and consequences of adequately managed chronic non-cancer pain and chronic neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012538.PUB2

Duloxetine use in chronic painful conditions--individual patient data responder analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012538.PUB2

Core outcome domains and measures for pediatric acute and chronic/recurrent pain clinical trials: PedIMMPACT recommendations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012538.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012538.PUB2

Opioids and the treatment of chronic pain: controversies, current status, and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012538.PUB2

Systematic review of the psychometric properties, interpretability and feasibility of self-report pain intensity measures for use in clinical trials in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012538.PUB2

Enriched enrollment: definition and effects of enrichment and dose in trials of pregabalin and gabapentin in neuropathic pain. A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012538.PUB2

Pregabalin in fibromyalgia--responder analysis from individual patient data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012538.PUB2

Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012538.PUB2

Acute pain management in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012538.PUB2

Systematic review of observational (behavioral) measures of pain for children and adolescents aged 3 to 18 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012538.PUB2

Opioids for cancer-related pain in children and adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012538.PUB2

Antiepileptic drugs for chronic non-cancer pain in children and adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012538.PUB2

Oral tramadol for the treatment of pain of 7-30 days' duration in children

21 January 2018

1 reference

12 December 2020

A comparative study of Propain and a dextropropoxyphene/paracetamol combination analgesic.

1 reference

12 December 2020

A double-blind comparative study of the analgesic effects of fenbufen, codeine, aspirin, propoxyphene and placebo

1 reference

12 December 2020

Comparison of ketorolac-chlorpromazine with meperidine-promethazine for treatment of exacerbations of chronic pain

1 reference

12 December 2020

Numbers-needed-to-treat analyses--do timing, dropouts, and outcome matter? Pooled analysis of two randomized, placebo-controlled chronic low back pain trials

1 reference

12 December 2020

Relief of severe pain with acetaminophen in a new dose formulation versus propoxyphene hydrochloride 65 mg. and placebo: a comparative double-blind study

1 reference

12 December 2020

Patient-centered perspective on treatment outcomes in chronic pain

1 reference

12 December 2020

10.1002/14651858.CD012538.PUB2

Identifiers

DOI

1 reference

1 July 2019

PMCID

6477875

1 reference

1 July 2019

PubMed ID

28745394

1 reference

1 July 2019